Li S, Gu HQ, Feng B, Dong Q, et al. RhPro-UK in acute ischemic stroke within 4.5 hours of stroke onset trial-2(The PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial. Int J Stroke 2024 Jun 22:17474930241265654. doi: 10.1177/17474930241265654.
PMID: 38907679